| 中文别名 |
(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-ij]喹啉)-4-(1H-吲哚)-2,5-吡咯烷二酮;(3R,4R)-3-(5,6-二氢-4H-吡咯并[3,2,1-IJ]喹啉-1-基)-4-(1H-吲哚-3-基)吡咯烷-2,5-二酮;3,11-二氯-6,11-二氢-6-甲基-二苯并[c,f][1,2]硫氮杂卓 5,5-二氧化物;祖师麻甲素.瑞香素 |
| 英文别名 |
(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;Tivantinib;ARQ 197;Tivantinib (ARQ 197);2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij] quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-;2,5-Pyrrolidinedione,3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R...;3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione;ARQ 197 (ARQ-197,Tivantinib);ARQ 197 (Tivantinib);ARQ-197;(-)-3(R),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;(-)-3(R),4(R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione,(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolid;TIVANTINIB ARQ-197;ARQ197;PJ4H73IL17;(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;Tivantinib [USAN:INN];Tivantinib; ARQ197;ARQ 197, Tivantinib;Tivantinib (JAN/USAN/INN);GTPL7948;(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione (ACI);CHEBI:91398;CHEBI:91398;CHEBI:91398;CHEBI:91398;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione;(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione;905853-99-8;905853-99-8;905853-99-8;905853-99-8;NSC800951;NSC800951;NSC800951;NSC800951;Q17123902;Q17123902;Q17123902;Q17123902;TIVANTINIB [USAN];TIVANTINIB [USAN];TIVANTINIB [USAN];DB12200;DB12200;TIVANTINIB [USAN];DB12200;SDCCGSBI-0654487.P001;DB12200;SDCCGSBI-0654487.P001;SDCCGSBI-0654487.P001;SDCCGSBI-0654487.P001;DA-67145;DA-67145;DA-67145;DA-67145;DA-68209;DA-68209;DA-68209;ARQ197; ARQ-197;Tivantinib;DA-68209;ARQ197; ARQ-197;Tivantinib;ARQ197; ARQ-197;Tivantinib;BCPP000042;ARQ197; ARQ-197;Tivantinib;TIVANTINIB [MI];BCPP000042;BCPP000042;BCPP000042;UCEQXRCJXIVODC-PMACEKPBSA-N;TIVANTINIB [MI];TIVANTINIB [MI];TIVANTINIB [MI];UCEQXRCJXIVODC-PMACEKPBSA-N;UCEQXRCJXIVODC-PMACEKPBSA-N;(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;UCEQXRCJXIVODC-PMACEKPBSA-N;(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;BRD-K33379087-001-01-8;(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione;BRD-K33379087-001-01-8;BRD-K33379087-001-01-8;CAS:905854-02-6;Tivantinib;BRD-K333... |
微信公众号
客服
